April 2007: Stem Cell & Cloning Research

Umbilical Cord Blood Storage Company Sees Growth Umbilical Cord Stem Cell Storage Resources Arkansas House Votes to Create Umbilical Cord Stem Cell Bank Scientists Claim They Discovered Molecule That Might Help Embryonic Stem Cells Grow US Senate Vote for Funding for Embryo-Destructive Stem Cell Research and Use of Frozen Human Embryos for Research Planned for 11 April 2007 UMBILICAL CORD BLOOD STORAGE COMPANY for Transplants Sees Enormous Growth in the amount of cord blood it has on hand. That after Congress and state legislatures have approved bills to promote awareness of using the embryonic stem cell research alternative. Cryobanks International's mission is to become the largest provider of cord blood stem cells for transplant and research purposes in the world and it's well on its way to fulfilling that goal.   With over 15,000 cord blood units processed and 9,000 listed on international registries for transplant, Cryobanks continues its push to help close the gap between patient needs and available resources of donated cord blood.   In recent years, cord blood transplants have become widely recognized as a safe, effective, and in many ways preferable, alternative to bone marrow transplant   According to Cryobanks' CEO, Dwight Brunoehler, over 35,000 American children and adults with life-threatening illnesses find themselves in need of a transplant each year. More than 150,000 people worldwide could be helped by cord blood transplants.   In a statement LifeNews.com received, Brunoehler said the company is committed to trying to use all cord blood it receives, including the 80% of donated units that do not meet the rigid transplant standards.   He said a variety of reasons including low...

Donating Umbilical Cord Blood for its Stem Cells: A Journal of How To Make a Difference

I was thrilled beyond words when my pregnancy test was positive.  My first thoughts were to tell all my family:  my six year old daughter first, I wanted her to tell her daddy; then our two year old and then the rest of our family.  My second thought – I want to donate the cord blood.  And then all the millions of other thoughts that come when you find out that you are expecting. I had read about storing the umbilical cord blood when I was expecting my second daughter… I had seen advertisements in baby magazines about private cord blood storage.  These companies charge a fee to store the umbilical cord blood so you can have access to the cord blood if you or a family member ever needs to use the blood for treatment.  I had heard through the pro-life group at my church that studies where having great results with stem cells from umbilical cord blood and I knew there must be a way for me to donate the cord blood.  I asked the director of our pro-life group for some suggestions and she recommended checking with the National Marrow Registry (www.marrow.org), searching the web, and then the Better Business Bureau. I began by searching the web for public cord blood banks.  Public banks store the cord blood without charge; if other people need the blood and it is a match, some of the cord blood is provided to them. More than likely, enough will still be available for your own family if the need should arise. I kept running across the name Cryobanks International even...

Human Umbilical Cord Blood Stem Cells Form Bone, Nerve, Heart Cells (ViaCell, 7/04)

Novel Unrestricted Somatic Stem Cells (USSCs) offer potential medical breakthrough — ViaCell, Inc., a cellular therapy company dedicated to enabling the widespread application of human cells as medicine, and the IntÂ’l NETCORD Fdn, the leading international network of public umbilical cord blood banks, announced the publication of a peer-reviewed article in The Journal of Experimental Medicine (JEM).  For the first time, using novel cells found in human umbilical cord blood, researchers have shown the ability to grow bone, cartilage, hematopoietic (blood), neural, liver and heart tissue in in vivo studies.  The article is entitled, “A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential”, 19July 2004 issue, vol. 200, no. 2, of JEM. Dr. Peter Wernet, the President of NETCORD, commented, “To our knowledge, we are the first group to demonstrate that neonatal somatic stem cells [i.e., stem cells from newborn babies] can be robustly expanded in vitro under pharmaceutical conditions to very large numbers and can differentiate, in vivo, into a number of tissue types and take on the properties and specific functions of the cells in those tissues.”  This discovery was made by Dr. Wernet, Dr. G. Koegler and scientists at ViaCell. This article describes the isolation and expansion of ViaCell’s proprietary USSC from human umbilical cord blood.  This cell type can be expanded in number under culture conditions published in the article.  The USSC has demonstrated a capacity to turn into several different cell types in vivo, including brain, bone, cartilage, liver, heart, and blood cells.  Previous experimental and clinical work has demonstrated the presence of blood-forming (hematopoietic) stem cells in...